Polymorphisms in the vitamin D receptor and their associations with risk of schizophrenia and selected anthropometric measures

被引:23
作者
Handoko, H
Nancarrow, DJ
Mowry, BJ
McGrath, JJ [1 ]
机构
[1] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Wacol, Qld 4076, Australia
[2] PO Royal Brisbane Univ, Queensland Inst Med Res, Brisbane, Qld 4029, Australia
[3] Univ Queensland, Dept Psychiat, St Lucia, Qld 4072, Australia
关键词
D O I
10.1002/ajhb.20504
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
The association between vitamin D levels and skeletal growth has long been recognized. However, exposure to low levels of vitamin D during early life is also known to alter brain development, and is a candidate risk factor for schizophrenia. This study examines the association between four polymorphisms in the vitamin D receptor (VDR) and 1) risk of schizophrenia, and 2) three anthropometric variables (height, head size, and head shape). Four single-nucleotide polymorphisms (SNPs; rs10735810/FokI, rsl544410/BsmI, rs7975232/ApaI, and rs731236/TaqI) in the VDR gene were genotyped in 179 individuals with schizophrenia and 189 healthy controls. No significant associations were detected between any of the four VDR SNPs and risk of schizophrenia. Patients were slightly but significantly shorter compared to controls. Of the four SNPs, only rs10735810/FokI was associated with any of the anthropometric measures: the M4 isoform of this SNP was significantly associated with larger head size (P = 0.002). In light of the evidence demonstrating a role for vitamin D during brain development, the association between polymorphisms in VDR and brain development warrants closer scrutiny.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 14 条
  • [1] Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty
    Abrams, SA
    Griffin, IJ
    Hawthorne, KM
    Chen, ZS
    Gunn, SK
    Wilde, M
    Darlington, G
    Shypailo, RJ
    Ellis, KJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (06) : 945 - 953
  • [2] Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3
    Colin, EM
    Weel, AEAM
    Uitterlinden, AG
    Buurman, CJ
    Birkenhäger, JC
    Pols, HAP
    van Leeuwen, JPTM
    van Leeuwen,
    [J]. CLINICAL ENDOCRINOLOGY, 2000, 52 (02) : 211 - 216
  • [3] Developmental Vitamin D3 deficiency alters the adult rat brain
    Féron, F
    Burne, THJ
    Brown, J
    Smith, E
    McGrath, JJ
    Mackay-Sim, A
    Eyles, DW
    [J]. BRAIN RESEARCH BULLETIN, 2005, 65 (02) : 141 - 148
  • [4] Gross C, 1996, J BONE MINER RES, V11, P1850
  • [5] Patterns of fetal and childhood growth and the development of psychosis in young males: A cohort study
    Gunnell, D
    Rasmussen, F
    Fouskakis, D
    Tynelius, P
    Harrison, G
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (04) : 291 - 300
  • [6] The vitamin D epidemic and its health consequences
    Holick, MF
    [J]. JOURNAL OF NUTRITION, 2005, 135 (11) : 2739S - 2748S
  • [7] Minor physical anomalies and quantitative measures of the head and face in patients with psychosis
    McGrath, J
    El-Saadi, O
    Grim, V
    Cardy, S
    Chapple, B
    Chant, D
    Lieberman, D
    Mowry, B
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (05) : 458 - 464
  • [8] Hypothesis: Is low prenatal vitamin D a risk-modifying factor for schizophrenia?
    McGrath, J
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 40 (03) : 173 - 177
  • [9] Vitamin D3 -: implications for brain development
    McGrath, JJ
    Féron, FP
    Burne, THJ
    Mackay-Sim, A
    Eyles, DW
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) : 557 - 560
  • [10] Is vitamin D hypothesis for schizophrenia valid?: Independent segregation of psychosis in a family with vitamin-D-dependent rickets type IIA
    Özer, S
    Ulusahin, A
    Ulusoy, S
    Okur, H
    Coskun, T
    Tuncali, T
    Gögüs, A
    Akarsu, AN
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (02) : 255 - 266